PERSON – Page 38

Pfizer Faces Key R&D Challenges as Chief Scientific Officer Mikael Dolsten Departs

10 months ago talkbio0Tagged Biopharma, Industry, Mikael, Pfizer, R&D, Scientific Officer

Pfizer, Mikael Dolsten, Chief Scientific Officer, R&D Challenges, Biopharma Industry

Arcutis Biotherapeutics Secures FDA Approval for ZORYVE Cream to Treat Atopic Dermatitis

10 months ago talkbio0Tagged Approved, Arcutis, biotherapeutics, Dermatitis, Atopic, Roflumilast Cream, Steroid-Free, United States Food and Drug Administration, Zoryve

Arcutis Biotherapeutics, ZORYVE, Atopic Dermatitis, FDA Approval, Roflumilast Cream, Steroid-Free Treatment

Pfizer’s R&D Chief Mikael Dolsten to Step Down After 15 Years of Leadership

10 months ago talkbio0Tagged COVID19 (disease), development aspects, Mikael, Pfizer, research, Scientific Officer, Successor Search, Vaccines

Pfizer, Mikael Dolsten, Chief Scientific Officer, Research and Development, COVID-19 Vaccine, Successor Search

Myricx Bio Secures £90m ($114m) Series A Financing to Advance Novel NMTi ADC Therapeutics

10 months ago talkbio0Tagged Bio, Eli Lilly, financing characteristics, Holdings, Malignant Neoplasms, Myricx, NMTi, Series, therapeutic autologous dendritic cells

Myricx Bio, Series A Financing, NMTi ADC Therapeutics, Novo Holdings, Lilly, Cancer Treatment

Annovis Bio Reports Promising Phase III Study Results for Buntanetap in Parkinson’s Disease Treatment

10 months ago talkbio0Tagged Annovis, Bio, buntanetap, Cognition, MDS-UPDRS, Motor function (observable entity), Neurodegenerative Disorders, Parkinson 's disease, Parkinson 's Disease Rating Scale, Phase 3 Clinical Trials, Unified - Type of Agreement

Annovis Bio, Buntanetap, Parkinson’s Disease, Phase III Study, Neurodegenerative Disorders, Cognitive Function, Motor Functions, Unified Parkinson’s Disease Rating Scale (MDS-UPDRS)